|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A01K 67/027 | |
| C07K 14/535 | |||
| C07K 14/715 | |||
| C07K 14/54 | |||
| C07K 14/52 | |||
| C07K 14/505 | |||
| C12N 9/00 | |||
| A61K 49/00 | |||
| G01N 33/50 | |||
| C07K 14/47 |
| (11) | Patento numeris | 3482629 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18214077.2 |
| Europos patento paraiškos padavimo data | 2015-05-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-05-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-11-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201462000460 P | 2014-05-19 | US |
| (72) |
MURPHY, Andrew J., US
STEVENS, Sean, US
FLAVELL, Richard, US
MANZ, Markus, CH
SHAN, Liang, US
|
| (73) |
Yale University,
Two Whitney Avenue, New Haven, CT 06510,
US
Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, US Institute for Research in Biomedicine (IRB), Via Vincenzo Vela 6,, 6501 Bellinzona, CH |
| (54) | GENETICALLY MODIFIED NON-HUMAN ANIMALS EXPRESSING HUMAN EPO |
| GENETICALLY MODIFIED NON-HUMAN ANIMALS EXPRESSING HUMAN EPO |